Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05682625
NCT05682625RecruitingNot Applicable

Understanding COVID-19 Vaccine Immunity in Tissue and Blood

Stanford University1 site in 1 country10 target enrollmentStarted: September 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
10
Locations
1
Primary Endpoint
Testing immune response to the COVID-19 vaccine over time
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to understand the effects of COVID-19 vaccines on the immune system and how the COVID-19 vaccines provide protection and induce long term memory. Adults who are receiving a COVID-19 vaccine will be invited to participate in this study.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults 18yrs old and higher who are receiving a COVID-19 vaccine

Exclusion Criteria

  • •Pregnancy
  • •Patients with contraindications for lymph node biopsy
  • •Active cancer
  • •Current use of immunosuppression drugs

Outcomes

Primary Outcomes

Testing immune response to the COVID-19 vaccine over time

Time Frame: 28 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

R. Sharon Chinthrajah

Associate professor

Stanford University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and DysregulationsImmunodeficienciesImmune Dysregulations
NCT04852276National Institute of Allergy and Infectious Diseases (NIAID)308
Terminated
Not Applicable
Immune Response to SARS-CoV-2 Vaccination in Systemic LupusSystemic Lupus
NCT04894253University Hospital, Strasbourg, France7
Completed
Not Applicable
Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese PopulationCOVID
NCT06763887Xijing Hospital100
Completed
Not Applicable
EVALUATION OF DIFFERENT PROPHYLACTIC INTERVENTIONS TOWARD COVID-19 IN SOLID ORGAN TRANSPLANT PATIENTSCOVID-19 PandemicTransplant-Related Disorder
NCT05629923University of Rome Tor Vergata306
Completed
Not Applicable
Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient PatientsAutoimmune Blistering DiseaseB-Cell DeficiencyMultiple Sclerosis
NCT05286242Yale University196
Understanding COVID-19 Vaccine Immunity in... | Clinical Trial